Lycia Therapeutics, Inc.
SEC Filing List

CIK: 0001806540

Company Information

First EDGAR Filing Last Filing Category Fiscal Year End
2020-03-17 2026-10-05 12/31
Exchange Current Cusip SIC Code State
2836-Biological Products, (No Diagnostic Substances) DE
SEC Company Name Former Names
Lycia Therapeutics, Inc.
Business Address Mailing Address
400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA 94080 400 EAST JAMIE COURT, SUITE 200, SOUTH SAN FRANCISCO, CA 94080